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Background: Obesity is a health problem that is reaching epidemic proportions worldwide. We investigated the
effects of a life-long high saturated fat and low carbohydrate (HF) diet on the body mass, glucose tolerance,
cognitive performance and lifespan of mice.
Findings: C57BL/6J mice were fed with a HF diet (60% kcal/fat) or control diets (15% kcal/fat) for 27 months.
One-half of the mice on the HF diet developed obesity (diet-induced obese (DIO) mice), whereas the remaining
mice were diet resistant (DR). At 8 months of age, both DIO and DR groups had increased hyperglycemic response
during a glucose tolerance test, which was normalized in 16-month-old mice. At this latter time point, all groups
presented similar performance in cognitive tests (Morris water maze and inhibitory avoidance). The survival curves
of the HF and control diet groups started to diverge at 15 months of age and, after 27 months, the survival rate of
mice in the DIO and DR groups was 40%, whereas in the control diet group it was 75%.
Conclusions: AHFdiet decreased the survival of mice independent of bodyweight.
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High-fat diet decreases survival
Obesity and overweight are associated with numerous
co-morbidities, including type 2 diabetes and neuro-
psychiatric disorders [1-3]. A sedentary lifestyle and ex-
cessive consumption of diets enriched in saturated fat
and/or high glucose contribute to the onset and progres-
sion of these co-morbidities [4,5] leading to decreased
life expectancy [6,7]. The effects of increased ingestion
of dietary fat and carbohydrate are well stabilized in ro-
dent models, leading to obesity and disturbed glucose
metabolism, similar to that seen in humans [8-10].
The ingestion of high-fat diets, rich in saturated fat,
lead to metabolic and neurochemical alterations, which* Correspondence: alexandrep.muller@gmail.com
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reproduction in any medium, provided the orcontribute to impaired performance of rodents in a var-
iety of behavioral tasks [8,11]. Both peripheral and
central perturbations, including hyperglycemia, altered
expression of synaptic proteins and signaling proteins,
are among the changes implicated in the deterioration of
the cognitive function [6].
One rodent strain that is particularly susceptible to
the effects of dietary fat is the C57BL/6 mouse [12].
C57BL/6 mice develop severe obesity, hyperglycemia
and hyperinsulinemia when fed a high-fat diet. How-
ever, when fat content is within the normal range ani-
mals remain lean and euglycemic [13]. Interestingly,
about 50% of C57BL/6 mice do not become obese when
fed with high-calorie diets [12,13] indicating individual
differences in terms of bodyweight gain under such
dietary conditions despite similar environment and
congenic genetic background [14,15].
In the present study, we aimed to identify changes as-
sociated with consumption of alife-long high saturated
fat and low carbohydrate (HF) diet on glucose tolerance,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mice, comparing those mice that developed obesity
(diet-induced obesity, DIO) to those that were resistant
to obesity (diet resistant; DR).
Availability of supporting data
Animals and diet
Twenty-five C57Bl6 male mice, aged 21 days, were ran-
domly placed on one of two different diets for 27
months: a control diet (CD, n = 12) or aHFdiet (n = 13).
The HF diet contained 60% energy from saturated and
unsaturated fat (45% lard and 15% soybean oil), 15% en-
ergy from starch (corn) and 25% from protein (soybean
protein). CD contained 15% energy from saturated fat
and unsaturated fat (soybean oil), 60% energy from
starch (corn) and 25% from protein (soybean protein).
Both diets were formulated in our laboratory and
contained standard vitamins and minerals mixed with all
essentials nutrients. Diets in the form of pellets and
water were provided ad libitum [7]. Animals were
weighedevery week during treatment. Mice were housed
in standard cages (20 × 15 cm), four animals per cage, in
a room with a controlled temperature (22°C) under a
12-hour light/12-hour dark cycle. All experiments were
in agreement with the Committee on Care and Use of
Experimental Animal Resources, Universidade Federal
do Rio Grande do Sul, Brazil.
Glucose tolerance test
At 8 and 16 months of age, mice were fasted for 12
hours and then received an intraperitoneal (i.p.) injec-
tion of glucose (2 mg/g body weight). Blood was drawn
from the tail and glucose levels was measured by a
glucosimeter at time 0 (fasting) and at 30, 60 and 120
minutes post-glucose injection (AccuChek Active, Roche
Diagnostics®, USA).
Morris water maze task
At 15 months of age, mice were subjected to a spatial
memory task as previously described [16]. The water
maze apparatus was a black circular pool (110 cm diam-
eter) with the water temperature maintained at 21 ± 1°C.
Mice were trained with two trials per day for 5consecu-
tive days, each trial lasting up to 60 seconds with 20 sec-
onds of rest on a hidden black platform. During training,
mice learned to escape from the water by finding a hid-
den rigid black platform submerged approximately 1 cm
below the water surface in a fixed location and, if it
failed to find the platform in 60 seconds, it was placed
gently on the platform and allowed to rest for 20 sec-
onds. The maze was located in a well-lit white room
with several visual stimuli hanging on the walls to pro-
vide spatial cues. Decreased time latency to escape dur-
ing each trial was measured as an indicator of learning.On the sixth day, a probe trial was performed without
the platform and the time spent in the target quadrant
was used as a measure of retention memory.
Inhibitory avoidance task
At 15 months of age, mice were also submitted to an
aversive memory task. The apparatus was a 50 × 25 × 25
cm acrylic box with a floor of parallel caliber stainless
steel bars (1 mm diameter) spaced 1 cm apart (Insight
Equipamentos, SP, Brazil). Mice were placed on the plat-
form located in the center of the apparatus and their
latencies to step down on the floor with all four paws
were measured with an automated device. During the
training sessions, when animals stepped down onto the
grid, they received a 1-second, 0.4-mA foot shock and
were immediately returned to their home cages. The test
sessions were performed without foot shock at 2 and 24
hours after training to evaluate short- and long-term
memory, respectively. The mice were returned to the
platform and the latency to step down (180 seconds
maximum) was used as a measure of retention [17]. A
foot shock was omitted during testing sessions. Data
from the inhibitory avoidance task are shown as median
(interquartile ranges) of latencies to step down on the
grid in both the test and training sessions.
Statistical analysis
Results are expressed as means ± S.E.M. except for data
from the inhibitory avoidance task, which is represented
by median and interquartile range. The data from the
water maze acquisitions task, glucose tolerance test
(GTT) and bodyweight were analyzed using a repeated-
measures analysis of variance (ANOVA), followed by
Duncan’s post-hoc test. Data from the inhibitory avoid-
ance task were analyzed by a Mann–Whitney U test.
Differences between groups were considered statistically
significant at P< 0.05. Cumulative survival probability
was plotted on a Kaplan–Meier curve with pairwise
comparisons of diets using the log-rank statistic analysis.
Bodyweight
As previously described by others [12,13], approximately
50% of the mice fed a HF diet became obese, whereas
the other 50% had similar bodyweight compared
to aged-matched control animals fed a control diet
(Figure 1A). Based on this data set, we stratified animals
fed a HF diet intoDR or DIO groups. Mice in the CD
and DR groups increased bodyweight for up to 9
months, which was maintained up to 21 months of age.
DIO mice still increased body weight for up to 15
months of age, and then this declined to reach the
weight of the CD and DR groups at 18 months. The
body weight of DIO mice was statistically different from
other groups from 6 to 15 months (P< 0.05, Figure 1A).
Figure 1 Body weight curves and glucose tolerance test. (A) Body weight curves (means ± S.E.M.) during the length of the study (*P< 0.05,
DIO> DR and CD). The glucose tolerance test (GTT) was performed (B) at 8 months (*P< 0.05, DIO and DR > CD; #P< 0.05, DIO > DR and CD) and
(C) 15 months after diet introduction (*P< 0.05, DIO > DR and CD; CD, n =12; high saturated fat and low carbohydratediet: DIO, n = 7; DR, n = 6).
Blood glucose levels (means ± S.E.M.) were assessed at fasting (0 minutes), 30, 60 and 120 minutes after an intraperitoneal glucose injection.
Insert: area under the curve (AUC) of the GTT.CD, control diet; DIO, diet-induced obese; DR, diet resistant.
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Next, we assessed glucose tolerance after 8 and 16
months of diet treatment. After 8 months of HF, both
DIO and DR mice had increased fasting blood glucose
levels (DR and DIO > CD, P< 0.05) and a robust hyper-
glycemic response during GTT relative to CD (DR and
DIO > CD, P< 0.05). In addition, DIO mice had long-
lasting hyperglycemia compared to CD and DR groups
(120 minutes DIO > CD and DR, P< 0.05, Figure 1B).
DR and DIO had increased area under the curve of
GTT (DIO > DR > CD, P< 0.05; Figure 1B insert). After
16 months on diet, the glucose profile during GTT was
attenuated: DIO mice showed an impaired GTT re-
sponse only at 60 minutes post i.p. glucose administra-
tion (P< 0.05, Figure 1C), and the area under the curve was
not statistically different among groups (Figure 1C, insert).Cognition tasks
Spatial (Morris water maze; MWM) and aversive (inhibi-
tory avoidance) memory was evaluated in 14- to 15-
month-old mice. In the MWM task, there was no
significant effect of HF diet on latency to find the plat-
form during the acquisition phase and probe trial
(Figure 2A,B). In the inhibitory avoidance task, all
groups showed an increased latency to step down the
platform in the training and test sessions (P< 0.05,
Figure 2C) with no differences among groups.Survival
At 15 months of age, the survival curves of the HF
groups and the CD group started to diverge and
remained separate until the end of treatment (Figure 3A).
At 27 months of age, the treatment was stopped. The
survival rate of HF mice (DIO and DR) was 40% and
that of the control diet mice was 75%. There was nostatistical difference in the survival rate between the
DIO and DR mice (Figure 3B).
The present study demonstrate that mice fed a HF diet
develop different phenotypes with regards to body
weight (DIO and DR) and glucose tolerance (impaired at
8 months and almost normal at 16 months), but showed
similar performance in memory tasks (spatial and
aversive) and mortality rate. Moreover, the increasing
mortality rate was dependent on dietary saturated fat
composition but independent of body weight gain.
As previously shown by others [14,15], we observed
that C57BL/6 mice fed a HF diet were either DR or DIO
related to body weight gain. The body weight gain ob-
served in DIO mice increased until mice were 15 months
old, similarly to Baur et al. [18]. However, the normal
age-associated body weight decline was greater in our
study and preceded those reported by Baur et al. [18].
Obesity is a key factor involved in the pathology of
diabetes and a risk factor to cardiovascular and cerebro-
vascular diseases. Mice fed with HF diets up to 8 months
were more resistant to a glucose load compared to CD-
treated mice. Blood glucose levels were elevated in DIO
mice during the whole course of the GTT, whereas DR
mice had increased glucose levels at fasting, 30 and 60
minutes during the GTT compared to CD mice, despite
their lean phenotype. At 16 months age, animals appear
to recover their ability to regulate peripheral glucose
levels; however, at this time-point we cannot rule out an
effect of age in glucose metabolism [19]. Moreover, sub-
tle alterations can take place in the early stages of high
saturated fat intake and can progress throughout the
course of years, modifying insulin levels and carbohy-
drate metabolism or insulin receptor response, thus
affecting peripheral tissues and brain metabolism.
A variety of studies have assumed that excessive HF con-
sumption causes obesity and contributes to disturbances
Figure 2 Performance on memory tasks after 16 months of
treatment. (A) Latency to find the platform during the acquisition
phase of the Morris water mazetest (means ± S.E.M.) and (B) time
spent in the target quadrant during the probe task (means ± S.E.M.).
(C) Inhibitory avoidance task latency to step down onto the platform
(median/interquartile ranges) during training and at the short- and
long-term memory tests. Controldiet(n = 12) and high fat diet
groups (diet-induced obese (DIO), n = 7; diet resistant (DR), n = 6).
*P< 0.05, test sections > training section.
Figure 3 Kaplan–Meier survival curves over 27 months. (A)
Survival based on treatment. Control diet (initial n = 12; final n=9)
and high fat diet (initial n = 13; final n = 5). (B) Survival based on
phenotype (initial diet-induced obese (DIO), n = 7; final n=2; initial
diet resistant (DR), n = 6; final n=3).
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neuronal signaling, neuron-to-glia connectivity and cogni-
tive functions [11,20]. Despite increased body weight at
the time of behavioral tasks along with impaired glucose
metabolism at earlier phases of HF, surprisingly DIO and
DR mice showed no cognitive decline in spatial or aversivememory tasks compared to CD mice. Differences in time
of regimen, diet composition, strain of animals and behav-
ioral protocols may potentially account for these dispar-
ities. Moreover, considering that a HF diet-induced
hyperglycemia during the early stages of treatment may
cause synaptic alterations we cannot rule out memory def-
icits after 15 month of age
In addition to investigating the detrimental effects of a
HF diet on cognitive function, we also examined its im-
plication on lifespan. Although the association of obesity
with increased risk of cardiovascular disease and dia-
betes is well known, it is often under-appreciated that
the risks of other age-related diseases, such as cancer
and inflammatory disorders, are also increased. Con-
versely, reducing caloric intake by 40% below that of
ad libitum-fed animals (caloric restriction) is the most ro-
bust and reproducible way to delay age-related diseases
and extend lifespan in mammals [21]. In this work, we
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months, ad libitum, had a decreased life expectancy and
further, when this group was stratified into DIO and DR
groups, the life expectancy curve was similar. Similarly,
Baur et al. [18] reported that a high calorie diet (60%
from fat) caused a deleterious impact on general health
status and survival rate in middle-aged mice. We were
not able to explain the exact mechanism by which a
HF diet increased mortality; however, the high energy
source from saturated fat over 27 months could be
implicated in increased reactive oxygen species produc-
tion and oxidative stress, which is the main process
responsible for aging and also a contributory factor for
neurodegeneration [22,23]. Also, activation of inflam-
matory and immunological response induced by a HF
diet and/or aging may exert a negative impact and be
implicated in the differences in life expectancy observed
in our study [21,24,25].
In conclusion, C57BL/6 mice fed a HF diet may de-
velop an obese phenotype or not compared to mice fed
a CD. A HF diet decreased the survival rate independent
of body weight gain.
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